Leveraging Northway Biotech’s 20+ years of CDMO expertise, Kaida BioPharma is advancing KAD101, a targeted therapy for ...

Nine states in the Southeast showed growth in bioscience employment and establishments from 2019 to 2023, according to 2024 ...

Known to develop the next generation of vaccines and medicines, with a focus on cell and gene therapies, the company started ...

Having already worked with clinical trial sites in more than 14 states, CTAC will now take its work nationwide, the ...

Find out the best way to find the right CDMO for your biotech. Experts shared some advice to help companies through the ...

Bharat Biotech to launch Hillchol, its oral cholera vaccine, amid a global shortage. With Phase III trials completed and 200M ...

Story May 5 - Unity Biotechnology: Aging-focused Bay Area ... The CRISPR-focused company is working to ensure it has "the right organization to drive forward our internal programs to the clinic ...

TrialWire™ is the risk-share pay-per-enrolled AI and algorithm-powered patient recruitment Platform built on Salesforce ...

President Trump announced a plan to reduce prescription drug prices by implementing a most-favored-nation policy with the ...

Hyderabad-based Bharat Biotech International Ltd. has claimed that its oral cholera vaccine (OCV) under development, Hillchol ...

Cancer research and treatment organization City of Hope has opened a $400 million outpatient facility in L.A. Check it out.